Global Biosurgery Market 2024 : Trends, Business Growth And Major Driving Factors | Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC

"The new report published by The Business Research Company, titled ""Biosurgery Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the biosurgery market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.18 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The biosurgery market size is expected to see strong growth in the next few years. It will grow to $20.87 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9380&type=smp

Rising Prevalence Of Chronic Diseases Fuels Biosurgery Market Growth
The increase in the prevalence of chronic disease is expected to propel the growth of the biosurgery market going forward. Chronic disease refers to health problems that persist for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. The main causes of death and disability in the US are chronic diseases such as diabetes, cancer, and heart disease. Biosurgery is used to eliminate dead tissue, lower the risk of infection, and speed up the healing process for chronic wounds. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-contained legal agency responsible for collecting and analyzing data as well as making evidence-based recommendations to federal, state, and territory governments, seventy-eight percent (78.6%) of Australians suffered from at least one chronic illness. 11.6 million individuals, or over half of the population, suffered from at least one chronic illness. Therefore, the increase in the prevalence of chronic disease is driving the growth of the biosurgery market.

Product Innovation To Revolutionize Wound Healing In The Biosurgery Market
Product innovations have emerged as the key trend gaining popularity in the biosurgery market. Major companies operating in the biosurgery market are developing product innovations to strengthen their position in the market. For instance, in April 2021, Aroa Biosurgery, a New Zealand-based manufacturer of medical and surgical products, launched Myriad Morcells, a Myriad Matrix morcellized (powder) configuration that easily adapts to improve interaction with uneven wound beds. It provides a burst of biologically significant ECM proteins in a format that fits the specifics of a wound in order to 'kick start' healing. A multi-layered extracellular matrix (ECM) graft with a high volume and surface area that has interstitial spaces that are quickly and easily accessible to cells is called Myriad Matrix. It makes use of the Aroa ECM bioscaffold technology, which incorporates crucial secondary chemicals and lingering vascular channels to assist the formation of new tissue.

The biosurgery market covered in this report is segmented -

1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9380&type=discount

Major companies operating in the biosurgery market report are Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Cyrolife Inc., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation .

Contents of the report:
1. Executive Summary
2. Biosurgery Market Report Structure
3. Biosurgery Market Trends And Strategies
4. Biosurgery Market - Macro Economic Scenario
5. Biosurgery Market Size And Growth
…..
27. Biosurgery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.